Concepedia

Olga Goloubeva

OG

Statistics

Publications

19

Citations

1.7K

H-Index

17

Active since

2002

Affiliations

University of Maryland, Baltimore(Current)

U-M Rogel Cancer Center

Dana-Farber Cancer Institute

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Harvard University

Olga Goloubeva is an author at University of Maryland, Baltimore specializing in oncology, medicine, and molecular oncology.

Publications per year

2002–2016

19

Publications

19

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

Richard LeBlanc, Laurence Catley, Teru Hideshima et al. · PubMed · 2002 · 456 citations

, , +13

Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole

Gauri Sabnis, Olga Goloubeva, Saranya Chumsri et al. · Cancer Research · 2011 · 157 citations · Full text

, , +17

Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model

Brian J. Long, Danijela Jelovac, Venkatesh Handratta et al. · JNCI Journal of the National Cancer Institute · 2004 · 145 citations · Full text

, , +15

High-Dose Spatially Fractionated GRID Radiation Therapy (SFGRT): A Comparison of Treatment Outcomes With Cerrobend vs. MLC SFGRT

Geoffrey Neuner, Majid Mohiuddin, Noam Vander Walde et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 128 citations

, , +14

Mitochondrial DNA Content Increase in Response to Cigarette Smoking

Brett G. Masayesva, Elizabeth Mambo, Rodney J. Taylor et al. · Cancer Epidemiology Biomarkers & Prevention · 2006 · 95 citations

, , +11

1–5 of 19